Northern Trust’s Utah Medical Products UTMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.88M Buy
30,292
+1,015
+3% +$63.9K ﹤0.01% 3009
2025
Q4
$1.64M Sell
29,277
-2,120
-7% -$123K ﹤0.01% 3111
2025
Q3
$1.98M Sell
31,397
-2,043
-6% -$121K ﹤0.01% 3045
2025
Q2
$1.9M Sell
33,440
-732
-2% -$39.8K ﹤0.01% 3014
2025
Q1
$1.91M Sell
34,172
-2,660
-7% -$159K ﹤0.01% 2946
2024
Q4
$2.26M Buy
36,832
+1,773
+5% +$115K ﹤0.01% 2957
2024
Q3
$2.35M Sell
35,059
-713
-2% -$48.4K ﹤0.01% 2902
2024
Q2
$2.39M Sell
35,772
-1,288
-3% -$87.7K ﹤0.01% 2805
2024
Q1
$2.64M Sell
37,060
-1,528
-4% -$115K ﹤0.01% 2822
2023
Q4
$3.25M Buy
38,588
+1,422
+4% +$118K ﹤0.01% 2721
2023
Q3
$3.2M Sell
37,166
-11
-0% -$1.01K ﹤0.01% 2684
2023
Q2
$3.46M Sell
37,177
-669
-2% -$63K ﹤0.01% 2704
2023
Q1
$3.59M Buy
37,846
+152
+0.4% +$14K ﹤0.01% 2652
2022
Q4
$3.79M Buy
37,694
+601
+2% +$54.9K ﹤0.01% 2654
2022
Q3
$3.16M Sell
37,093
-141
-0.4% -$12.4K ﹤0.01% 2760
2022
Q2
$3.2M Buy
37,234
+194
+0.5% +$16.5K ﹤0.01% 2802
2022
Q1
$3.33M Sell
37,040
-1,360
-4% -$125K ﹤0.01% 2823
2021
Q4
$3.84M Sell
38,400
-526
-1% -$53.7K ﹤0.01% 2855
2021
Q3
$3.61M Sell
38,926
-1,609
-4% -$142K ﹤0.01% 2942
2021
Q2
$3.45M Sell
40,535
-2,611
-6% -$226K ﹤0.01% 3060
2021
Q1
$3.74M Sell
43,146
-8,245
-16% -$725K ﹤0.01% 2922
2020
Q4
$4.33M Sell
51,391
-3,696
-7% -$315K ﹤0.01% 2764
2020
Q3
$4.4M Sell
55,087
-1,996
-3% -$166K ﹤0.01% 2623
2020
Q2
$5.06M Sell
57,083
-300
-0.5% -$26.9K ﹤0.01% 2512
2020
Q1
$5.4M Buy
57,383
+1,192
+2% +$111K ﹤0.01% 2263
2019
Q4
$6.06M Sell
56,191
-875
-2% -$88.7K ﹤0.01% 2475
2019
Q3
$5.47M Buy
57,066
+2,686
+5% +$250K ﹤0.01% 2499
2019
Q2
$5.21M Sell
54,380
-719
-1% -$60.5K ﹤0.01% 2538
2019
Q1
$4.86M Buy
55,099
+251
+0.5% +$22.1K ﹤0.01% 2583
2018
Q4
$4.56M Sell
54,848
-1,807
-3% -$159K ﹤0.01% 2561
2018
Q3
$5.34M Buy
56,655
+1,249
+2% +$119K ﹤0.01% 2652
2018
Q2
$6.1M Buy
55,406
+2,158
+4% +$225K ﹤0.01% 2582
2018
Q1
$5.26M Buy
53,248
+388
+0.7% +$34.6K ﹤0.01% 2551
2017
Q4
$4.3M Buy
52,860
+148
+0.3% +$11.6K ﹤0.01% 2698
2017
Q3
$3.88M Sell
52,712
-582
-1% -$41.9K ﹤0.01% 2793
2017
Q2
$3.86M Buy
53,294
+305
+0.6% +$20.1K ﹤0.01% 2774
2017
Q1
$3.3M Buy
52,989
+916
+2% +$57.7K ﹤0.01% 2807
2016
Q4
$3.79M Buy
52,073
+761
+1% +$49.5K ﹤0.01% 2729
2016
Q3
$3.07M Buy
51,312
+1,103
+2% +$70.2K ﹤0.01% 2829
2016
Q2
$3.16M Sell
50,209
-2,489
-5% -$161K ﹤0.01% 2766
2016
Q1
$3.3M Buy
52,698
+905
+2% +$53.4K ﹤0.01% 2682
2015
Q4
$3.03M Sell
51,793
-48
-0.1% -$2.72K ﹤0.01% 2791
2015
Q3
$2.79M Buy
51,841
+515
+1% +$28.1K ﹤0.01% 2834
2015
Q2
$3.06M Sell
51,326
-1,353
-3% -$76.2K ﹤0.01% 2829
2015
Q1
$3.15M Sell
52,679
-1,934
-4% -$114K ﹤0.01% 2813
2014
Q4
$3.28M Buy
54,613
+189
+0.3% +$10.5K ﹤0.01% 2773
2014
Q3
$2.65M Buy
54,424
+4,068
+8% +$207K ﹤0.01% 2910
2014
Q2
$2.59M Sell
50,356
-5,507
-10% -$283K ﹤0.01% 2926
2014
Q1
$3.23M Sell
55,863
-2,535
-4% -$138K ﹤0.01% 2838
2013
Q4
$3.34M Buy
58,398
+590
+1% +$32.4K ﹤0.01% 2835
2013
Q3
$3.44M Sell
57,808
-2,855
-5% -$156K ﹤0.01% 2751
2013
Q2
$3.29M Buy
+60,663
New +$2.86M ﹤0.01% 2678

Other funds holding UTMD

Northern Trust's UTMD Position: Q1 2026 in Review

Northern Trust increased its Utah Medical Products (UTMD) stake by 3.5% in Q1 2026, buying an estimated $63.9K and bringing the position to 30,292 shares worth $1.88M. The position accounts for ﹤0.01% of the portfolio, ranked #3009.

Northern Trust first reported a position in UTMD in Q2 2013 and has held it in 52 quarters since. The position peaked at $6.1M in Q2 2018. 119 funds tracked by Wall St. Rank hold UTMD as of Q1 2026.

  • Northern Trust held 30,292 shares of Utah Medical Products worth $1.88M as of Q1 2026.
  • Northern Trust bought 1,015 Utah Medical Products shares in Q1 2026, an estimated $63.9K.
  • Utah Medical Products made up ﹤0.01% of Northern Trust's portfolio in Q1 2026, its #3009 holding.
  • Northern Trust first reported a position in Utah Medical Products in Q2 2013 and has held it in 52 quarters since.
  • Northern Trust's Utah Medical Products position peaked at $6.1M in Q2 2018.
  • 119 funds tracked by Wall St. Rank held Utah Medical Products as of Q1 2026.

Based on Northern Trust's 13F filing for Q1 2026, filed 14 May 2026.